Investing in Life Science – Learnings From the First Round of Investments From Discovery Park Ventures
Investing in life science companies is both challenging and rewarding. The sector is constantly evolving and comes with a lot of unknowns and risks, especially at the commercialisation stage. However, with the potential to help create a positive impact to society and...
FemTech and Women’s Health Start-Ups Urged to Join Discovery Park’s Growth Programme, Offering a Support Package Worth Over £50K
Discovery Park, Kent’s thriving life science community, has launched a special edition of their growth and support programme, Discovery Spark, for start-ups in FemTech and Women’s Health. The programme was unveiled at Kent & Medway Women’s Health Innovation...
Mayer Schreiber, CEO of Discovery Park Gives His Views on the Spring Budget
“The Chancellor has rightly prioritised life sciences as an area of high growth in this and his previous fiscal statements. The UK has a real opportunity to solidify our position as one of the world leaders in the area. “I welcome the announcement from the...
Neobe Therapeutics Raises Over $2m for Synthetic Biology Enabled Tumour Microenvironment Remodelling
Neobe Therapeutics, a pioneering synthetic biology startup at the forefront of immuno-oncology innovation, is thrilled to announce the successful closure of a $2.34M financing round. This significant financial milestone was achieved with the support of new investors...

